| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 60.736 | 85.174 | 72.991 | 70.375 | 15.829 |
| Total Income - EUR | - | - | - | - | - | 67.578 | 107.801 | 73.330 | 70.375 | 15.829 |
| Total Expenses - EUR | - | - | - | - | - | 66.576 | 99.602 | 89.750 | 68.965 | 12.654 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 1.002 | 8.199 | -16.421 | 1.411 | 3.175 |
| Net Profit/Loss - EUR | - | - | - | - | - | 794 | 7.452 | -17.049 | 719 | 2.770 |
| Employees | - | - | - | - | - | 4 | 3 | 3 | 1 | 1 |
Check the financial reports for the company - Dorna Biocom S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 1.738 | 1.699 | 5.231 | 4.809 | 4.379 |
| Current Assets | - | - | - | - | - | 28.891 | 31.731 | 14.516 | 22.527 | 28.239 |
| Inventories | - | - | - | - | - | 4.463 | 2.417 | 4.020 | -131 | 67 |
| Receivables | - | - | - | - | - | 22.187 | 18.194 | 2.286 | 868 | -72 |
| Cash | - | - | - | - | - | 2.241 | 11.120 | 8.211 | 21.791 | 28.244 |
| Shareholders Funds | - | - | - | - | - | 23.074 | 30.015 | 13.059 | 13.738 | 16.430 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 7.555 | 3.415 | 8.209 | 13.599 | 16.187 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Dorna Biocom S.r.l.